Business Context and Reporting Period
Company: ILLUMINA, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: January 8, 2013
Reporting Period: Fourth quarter ended December 30, 2012
Context: The Company presented preliminary financial results at the J.P. Morgan Healthcare Conference in San Francisco, California.
Key Financial Metrics
- Total Revenue (Q4 2012): $309 million (Preliminary)
- Earnings Per Share (EPS): Non-GAAP EPS expected to track to the mid-point of the guidance range provided in the prior period.
- Cash Flow, Margins, Debt, Liquidity: The filing text does not provide clear values for these specific metrics.
Material Changes
The filing reports preliminary revenue figures for the fourth quarter. No specific comparative data or percentage changes versus the prior comparable period are provided in this text.
Guidance, Outlook, and Management Commentary
- Outlook: Management expects non-GAAP EPS to align with the mid-point of the previously issued guidance range.
- Next Steps: Full quarterly results and fiscal year 2012 earnings will be announced during the Company's upcoming earnings call.
- Disclaimer: The revenue figure is based on preliminary financial analysis and remains subject to audit by the independent registered public accounting firm.
Investor Verification Checklist
- Verify the final audited revenue figure against the preliminary $309 million reported.
- Confirm the specific guidance range referenced for the non-GAAP EPS mid-point projection.
- Review the full earnings call transcript for details on margins, cash flow, and debt not included in this 8-K.
- Check for any subsequent filings regarding the audit status of the preliminary results.